Literature DB >> 21946164

Long-term outcomes of kidney donors.

Benjamin R Morgan1, Hassan N Ibrahim.   

Abstract

PURPOSE OF REVIEW: Living kidney donors face a unique decision of self-sacrifice that is not without potential risk. The purpose of this review is to highlight existing research regarding the perioperative morbidity, mortality and long-term outcomes of living kidney donors. RECENT
FINDINGS: Recent studies of long-term donor survival have affirmed that the life expectancy for living kidney donors is excellent and their risk of end-stage renal disease (ESRD) is not increased. Long-term health outcomes for living donors representing minority groups, however, may not be as favorable. Recent studies conclude that African-American and Hispanic donors, similarly to nondonors of the same race, are at higher risk of developing chronic kidney disease (CKD), hypertension, and diabetes mellitus. Outcomes in medically complex donors have also generated considerable attention, and the evidence on outcomes among otherwise healthy obese and older donors appears to be reassuring.
SUMMARY: Living kidney donation is a superior transplantation option for many individuals with ESRD. The survival and health consequences of living donation have proven to be excellent. These favorable outcomes stem from careful screening measures, and further research endeavors are needed to ensure long-term living donor safety in high-risk donors.

Entities:  

Mesh:

Year:  2011        PMID: 21946164     DOI: 10.1097/MNH.0b013e32834bd72b

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  9 in total

1.  Development and validation of a questionnaire to assess fear of kidney failure following living donation.

Authors:  James R Rodrigue; Aaron Fleishman; Tanya Vishnevsky; James Whiting; John P Vella; Krista Garrison; Deonna Moore; Liise Kayler; Prabhakar Baliga; Kenneth D Chavin; Seth Karp; Didier A Mandelbrot
Journal:  Transpl Int       Date:  2014-03-29       Impact factor: 3.782

2.  Readiness of wait-listed black patients to pursue live donor kidney transplant.

Authors:  James R Rodrigue; Matthew J Paek; Ogo Egbuna; Amy D Waterman; Jesse D Schold; Martha Pavlakis; Didier A Mandelbrot
Journal:  Prog Transplant       Date:  2014-12       Impact factor: 1.187

3.  Low birthweight and risk of albuminuria in living kidney donors.

Authors:  Danielle Berglund; David MacDonald; Scott Jackson; Richard Spong; Naim Issa; Aleksandra Kukla; Scott Reule; Marc Weber; Arthur J Matas; Hassan N Ibrahim
Journal:  Clin Transplant       Date:  2014-02-19       Impact factor: 2.863

4.  Glomerular filtration rate in prospective living kidney donors.

Authors:  Glen M Blake; Christopher Sibley-Allen; Rachel Hilton; Lisa Burnapp; Masood R Moghul; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2013-03-06       Impact factor: 2.370

5.  Chronic Kidney Disease: The Complex History of the Organization of Long-Term Care and Bioethics. Why Now, More Than Ever, Action is Needed.

Authors:  Elisabetta Versino; Giorgina Barbara Piccoli
Journal:  Int J Environ Res Public Health       Date:  2019-03-04       Impact factor: 3.390

6.  Compensatory renal hypertrophy following uninephrectomy is calcineurin-independent.

Authors:  Clintoria R Williams; Brandi M Wynne; Makeeva Walker; Robert S Hoover; Jennifer L Gooch
Journal:  J Cell Mol Med       Date:  2014-10-07       Impact factor: 5.310

Review 7.  Renal transplantation from elderly living donors.

Authors:  Jacob A Akoh; Umasankar Mathuram Thiyagarajan
Journal:  J Transplant       Date:  2013-09-12

8.  Investigating kidney donation as a risk factor for hypertension and microalbuminuria: findings from the Swiss prospective follow-up of living kidney donors.

Authors:  Gilbert T Thiel; Christa Nolte; Dimitrios Tsinalis; Jürg Steiger; Lucas M Bachmann
Journal:  BMJ Open       Date:  2016-03-22       Impact factor: 2.692

9.  Hand-assisted living-donor nephrectomy: a retrospective comparison of two techniques.

Authors:  Jeannette D Widmer; Andrea Schlegel; Philipp Kron; Marc Schiesser; Jens G Brockmann; Markus K Muller
Journal:  BMC Urol       Date:  2018-05-10       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.